Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Lipocine (LPCN) Revenue (2018 - 2025)

Historic Revenue for Lipocine (LPCN) over the last 8 years, with Q3 2025 value amounting to $114574.0.

  • Lipocine's Revenue changed N/A to $114574.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.3 million, marking a year-over-year decrease of 4229.14%. This contributed to the annual value of $11.2 million for FY2024, which is 29280.46% up from last year.
  • According to the latest figures from Q3 2025, Lipocine's Revenue is $114574.0.
  • Lipocine's 5-year Revenue high stood at $16.1 million for Q4 2021, and its period low was -$216188.0 during Q4 2023.
  • Over the past 5 years, Lipocine's median Revenue value was $114574.0 (recorded in 2025), while the average stood at $2.4 million.
  • In the last 5 years, Lipocine's Revenue soared by 1375192.58% in 2024 and then crashed by 9876.77% in 2025.
  • Over the past 5 years, Lipocine's Revenue (Quarter) stood at $16.1 million in 2021, then tumbled by 96.89% to $500000.0 in 2022, then crashed by 143.24% to -$216188.0 in 2023, then skyrocketed by 1714.99% to $3.5 million in 2024, then tumbled by 96.72% to $114574.0 in 2025.
  • Its Revenue was $114574.0 in Q3 2025, compared to $622849.0 in Q2 2025 and $93864.0 in Q1 2025.